Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/07/2010US20100256088 Low dose therapy for treating viral infections
10/07/2010US20100256087 Compositions for the treatment or prophylaxis of viral infections
10/07/2010US20100256086 Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof
10/07/2010US20100256085 Toll-Like Receptor Agonist Regulation of VEGF-Induced Tissue Responses
10/07/2010US20100256084 Biological marker for inflammation
10/07/2010US20100256083 Organ protection, preservation and recovery
10/07/2010US20100256082 Metallo-hydrolase inhibitors using metal binding moietes in combination with targeting moieties
10/07/2010US20100256081 Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
10/07/2010US20100256080 Organic compounds
10/07/2010US20100256079 Eriocitrin-containing material, method for production of the eriocitrin-containing material, and food, beverage, pharmaceutical preparation and cosmetic each comprising the erocitrin-containing material
10/07/2010US20100256078 Neoglycorandomization and digitoxin analogs
10/07/2010US20100256077 Core 2GlcNAc-T inhibitors
10/07/2010US20100256076 Compositions and Methods Related to Calcitriol
10/07/2010US20100256072 Therapeutic agents for the treatment of leukemia
10/07/2010US20100256071 CHD5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
10/07/2010US20100256064 Delivery device and method
10/07/2010US20100256057 Method of preventing or treating body weight disorders by employing clusterin
10/07/2010US20100256045 Use of Measles Virus Nucleoprotein for Treating Atherosclerosis
10/07/2010US20100256038 Th-17 cells
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255501 Method of identifying a mhc class i restricted t cell response
10/07/2010US20100255130 Aloe preparation for skin enhancement
10/07/2010US20100255126 Medicament for treatment of cancer and other diseases
10/07/2010US20100255117 Methods and compositions for the treatment of cancer
10/07/2010US20100255112 Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes
10/07/2010US20100255109 Stabilized antioxidant particles, composition comprising the same and method for preparing the same
10/07/2010US20100255107 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
10/07/2010US20100255106 Benzothiophenes, formulations containing same, and methods
10/07/2010US20100255105 Extended release pharmaceutical composition comprising metoprolol succinate
10/07/2010US20100255104 Pharmaceutical formulation of taxane
10/07/2010US20100255103 Mesoporous Silica Nanoparticles for Biomedical Applications
10/07/2010US20100255102 Sterilization of dispersions of nanoparticulate active agents with gamma radiation
10/07/2010US20100255101 Dextran-based polymer tissue adhesive for medical use
10/07/2010US20100255099 Clavulanate formulation for neuroprotection and treatment of neurodegenerative disorders
10/07/2010US20100255097 Polysaccharide derivatives of lipoic acid, and their preparation and use as skin cosmetics and medical devices
10/07/2010US20100255096 Compositions And Methods For Transmucosal Delivery Of Domperidone
10/07/2010US20100255095 Pharmaceutical compositions of fenofibrate
10/07/2010US20100255094 Bupropion hydrobromide and therapeutic applications
10/07/2010US20100255093 Sustained release oral dosage forms of an r-baclofen prodrug
10/07/2010US20100255092 Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
10/07/2010US20100255091 Oral fast disintegrating tablets
10/07/2010US20100255090 Controlled release matrix pharmaceutical dosage formulation
10/07/2010US20100255089 Pharmaceutical Compositions and Methods of Using Same
10/07/2010US20100255088 Method for delivering a combination of resveratrol and aspirin for use in treatment and prevention of vascular disease
10/07/2010US20100255086 Method for oral mucosal absorption of acetyl salycylic acid
10/07/2010US20100255085 Progesterone Solutions for Increased Bioavailability
10/07/2010US20100255083 Controlled-release pharmaceutical formulation and process for its preparation
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255080 Liposomal ALA pharmaceutical and cosmeceutical compositions and methods of treatment
10/07/2010US20100255079 Systems and methods for skin rejuvenation
10/07/2010US20100255077 Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids
10/07/2010US20100255076 Composition and method for dermal regeneration
10/07/2010US20100255075 CR-2 Binding Peptide P28 as Molecular Adjuvant for DNA Vaccines
10/07/2010US20100255073 Composition for transdermal delivery of fentanyl
10/07/2010US20100255071 Patch and patch preparation
10/07/2010US20100255069 Compositions and methods for treating angiogenesis-related diseases, wounds and cosmetic use of components of angelica sinensis, and methods of preparation thereof
10/07/2010US20100255067 Controlled Release Pharmaceutical Compositions of Pregabalin
10/07/2010US20100255064 Compressed Chewing Gum Tablet
10/07/2010US20100255063 Compressed Chewing Gum Tablet
10/07/2010US20100255061 Posterior Segment Drug Delivery
10/07/2010US20100255058 Biocompatible polyacrylate compositions for medical applications
10/07/2010US20100255057 Device for actively removing a target cell from blood or lymph of a vertebrate subject
10/07/2010US20100255055 Gold-coated stent coated/plated the chemicals and oligonucleotide binding gold-coated stent and process for producing the same
10/07/2010US20100255054 Pharmaceutical composition for treatment and prevention of restenosis
10/07/2010US20100255051 Polyketal polymers, and methods of making and using same
10/07/2010US20100255050 Polyethylene Based Bioactive Agents
10/07/2010US20100255045 Composition for photodynamic skin treatment
10/07/2010US20100255041 Remedy for the treatment of cardio-vascular diseases or disorders
10/07/2010US20100255030 Avirulent, immunogenic flavivirus chimeras
10/07/2010US20100255029 Newcastle disease virus vectored avian vaccines
10/07/2010US20100255027 Papilloma pseudovirus and preparation
10/07/2010US20100255016 Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
10/07/2010US20100255009 Methods for Inducing Mixed Donor-Recipient Chimerism in an Allograft Transplant Recipient
10/07/2010US20100255006 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
10/07/2010US20100255005 Gamma secretase modulators
10/07/2010US20100255004 Receptor tyrosine kinase profiling
10/07/2010US20100255001 Blockers of serotonin and its receptors for the treatment of hepatitis
10/07/2010US20100254999 Eg-vegf nucleic acids and polypeptides and methods of use
10/07/2010US20100254998 Method for prolonging longevity
10/07/2010US20100254996 Synergistic treatment of cells that express epha2 and erbb2
10/07/2010US20100254991 Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment
10/07/2010US20100254990 Anti-ngf antibodies for the treatment of various disorders
10/07/2010US20100254983 Uses of rage antagonists for treating obesity and related diseases
10/07/2010US20100254982 Cancer specific antibody and cell surface proteins
10/07/2010US20100254976 Use of protease nexin 1 inhibitors to reduce metastasis
10/07/2010US20100254965 Adenosine Signaling in Diagnosis, Treatment, and Prevention of Priapism and Erectile Dysfunction
10/07/2010US20100254962 Functional drink
10/07/2010US20100254961 Water-soluble electrospun sheet
10/07/2010US20100254959 Naphthalene isoxazoline invertebrate pest control agents
10/07/2010US20100254949 Prebiotic oligosaccharides
10/07/2010US20100254948 Process for the preparation of gamma-amino butyric acid (gaba) by the use of lactic acid bacteria (lab) on agro-and food-industry surplus
10/07/2010US20100254946 Maintenance of hair growth and treatment of hair-loss
10/07/2010US20100254942 Hepatitis c antiviral compositions and methods
10/07/2010US20100254941 Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
10/07/2010US20100254940 Compositions and Methods for Regulating an Immune Response in a Subject
10/07/2010US20100254939 Graft copolymers as drug delivery systems
10/07/2010US20100254935 Amine condensation polymers as phosphate sequestrants
10/07/2010US20100254934 Ophthalmic Compositions Comprising Povidone-Iodine
10/07/2010US20100254928 Novel composition containing ozonized surfactant
10/07/2010US20100254925 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and use thereof as an antimicrobial active ingredient
1 ... 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 ... 7860